Revenue
2021
2022
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue | £53.8M | £54.1M | £53.2M | £58.6M | £61.2M | £61.6M |
| Gross profit | £24.2M | £24.2M | £22.8M | £24.3M | £26.2M | £25.0M |
| Gross margin | 44.91% | 44.67% | 42.92% | 41.57% | 42.77% | 40.55% |
| Research & development | −£215,000 | −£127,000 | £0 | — | — | — |
| Operating expenses | £21.3M | £20.5M | £25.8M | £22.9M | £21.8M | £19.6M |
| Operating income | £2.9M | £3.7M | −£2.9M | £1.4M | £4.4M | £5.4M |
| Operating margin | 5.40% | 6.77% | −5.50% | 2.42% | 7.14% | 8.75% |
| EBITDA | £4.5M | £5.2M | −£1.2M | £2.7M | — | — |
| EBITDA margin | 8.34% | 9.70% | −2.27% | 4.59% | — | — |
| Net income | £2.1M | £2.5M | −£3.5M | £514,000 | £3.1M | £4.3M |
| Net profit margin | 3.88% | 4.54% | −6.63% | 0.88% | 5.09% | 7.04% |
| Basic EPSper basic share | £0.03 | £0.04 | -£0.05 | £0.01 | £0.05 | £0.07 |
| Diluted EPSper diluted share | £0.03 | £0.03 | -£0.05 | £0.01 | £0.04 | £0.06 |